From: Neuroendocrine liver metastasis from the small intestine: Is surgery beneficial for survival?
Treatment | Estimated cumulative survival (Kaplan–Meier) | |||||
---|---|---|---|---|---|---|
1-year survival | 5-year survival | 10-year survival | 20-year survival | |||
Group 1 | Surveillance | n = 52 | 86.5 ± 4.4% [49] | 68.8 ± 6.4% [33 | 24.3 ± 6.6% [9] | 3.4 ± 3.2 [1] |
Group 2 | Surgery | n = 22 | 96.0 ± 3.9% [21] | 73.9 ± 10.2% [11] | 60.5 ± 12% [6] | 0 |
Subgroup 2a | Minor liver surgery (≤ 1 segment) | n = 15 | 94.1 ± 5.7% [14] | 76.7 ± 12.2% [6] | 63.9 ± 15.5% [3] | 0 |
Subgroup 2b | Major liver surgery (> 1 segment) | n = 7 | 100% [7a] | 71.4 ± 17.1% [5] | 57.1 ± 18.7% [3] | 0 |